CGB-500

tofacitinib · CAGE Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CGB-500, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis [Phase 2]

See pricing